Biotech Values

[mcbio]

Re: PYMX

In other words, there are a lot of ifs that have to work out for PYMX’s reversing agent to be a commercial success; if you decide to invest in PYMX, I think you should do it for the antibiotic program rather than the protamine-replacement program.

Thanks Dew, very informative response and makes a lot of sense. I'm not planning on investing or anything right now. I just always like to learn more about, and keep an eye on, these biotechs with sub-$100 million market caps and potentially novel programs.